CellCept is a prescription drug used to help prevent organ rejection after a transplant. Learn about the drug’s dosages, forms, strengths, and more. Medical News Today ...

Learn about the dosages for CellCept in preventing organ rejection following transplant. You can also find information on the drug’s strengths, forms, and more.

But after 30 years with no new treatments, some doctors have welcomed a drug called CellCept, which they are predicting will yield a much-improved quality of life for lupus patients, ...

The FDA has approved orphan drug status for mycophenolate mofetil (CellCept), a second-generation antisense drug (ISIS 301012), and a 5-membered heterocyclic anti-sickling compound (5-HMF).

Malaysia has approved a new indication for mycophenolate mofetil (CellCept), and the EU has granted a new orphan drug indication for mecasermin rinfabate [rDNA origin] injection (iPlex).

TORONTO, June 4 /PRNewswire/ -- The 12-month results from a multicenter trial monitoring CellCept(R) (mycophenolate mofetil) in combination with calcineurin inhibitors (CNIs) in renal transplantation ...